Polaryx Therapeutics, Inc. (PLYX)

Price & Market Data

Price: $3.69

Daily Change: -$0.25 / 6.78%

Daily Range: $3.54 - $4.29

Market Cap: $170,435,856

Daily Volume: 174,297

Performance Metrics

1 Week: 14.62%

1 Month: -26.18%

3 Months: 55.56%

6 Months: -91.29%

1 Year: -91.29%

YTD: -91.29%

About Polaryx Therapeutics, Inc. (PLYX)

A complete market overview for Polaryx Therapeutics, Inc. (PLYX). The stock is at 3.69, with a daily change of -$0.25 / 6.78%. Market cap: 170,435,856. Delve into its YTD and 3-month performance.

Company Details

Employees: 11

Sector: Commercial services

Industry: Miscellaneous commercial services

Country: United States

Details

Polaryx Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of disease-modifying therapies for rare and pediatric lysosomal storage disorders in the United States. Its pipeline includes PLX-100, a preclinical stage orally administrable combination therapy; PLX-200, a repurposed oral small molecule for the treatment of LSDs; PLX-300, a preclinical stage orally administrable combination therapy; and PLX-400, a preclinical stage novel gene therapy candidate. The company was founded in 2014 and is based in Paramus, New Jersey.

Selected stocks

SIGA Technologies Inc. (SIGA)

Foresight Autonomous Holdings Ltd. (FRSX)

The GrowHub Limited (TGHL)

Aemetis, Inc (AMTX)

Precision Optics Corporation, Inc. (POCI)